Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Dobkin

Showing results (21-30 of 61) with videos related to

Pageof 7
Sort By:
Journal of Geriatric Psychiatry and Neurology|June 28, 2018
Personalized Telemedicine for Depression in Parkinson's Disease: A Pilot TrialRoseanne D Dobkin, Alejandro Interian, John Logan Durland, et al.
The Journal of Trauma|October 1, 1995
Hypopituitarism secondary to transfacial gunshot woundM D'Angelica, C A Barba, A S Morgan, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 26, 2024
Defining the Importance of Minor Hallucinations in Parkinson's DiseaseRuth B Schneider, Kelly A Mills, Melissa J Nirenberg, et al.
Clinical Immunology and Immunopathology|January 1, 1976
Lymphokine properties of a lymphoid cultured cell supernatant fraction active in promoting tumor regressionB W Papermaster, O A Holtermann, E Klein, et al.
Journal of Pediatric Surgery|June 1, 1986
Comparative effects of dopamine, naloxone, and prostacyclin in the resuscitation of fecal-Escherichia coli peritonitis-induced septic shock in neonatal swineT E Lobe, E D Dobkin, D Gore, et al.
Clinical Case Studies|April 27, 2010
A Novel Approach to Treating Anxiety and Enhancing Executive Skills in an Older Adult with Parkinson's DiseaseJan Mohlman, Dorian Hunter Reel, Daniel Chazin, et al.
Journal of Geriatric Psychiatry and Neurology|April 17, 2013
Barriers to mental health care utilization in Parkinson's diseaseRoseanne D Dobkin, Jade Tiu Rubino, Jill Friedman, et al.
Neurology|April 3, 2020
Telephone-based cognitive behavioral therapy for depression in Parkinson disease: A randomized controlled trialRoseanne D Dobkin, Sarah L Mann, Michael A Gara, et al.
Annals of Neurology|May 13, 2026
Cognitive Impairment in Parkinson's Disease: Contributions from the Parkinson's Progression Markers InitiativeDaniel Weintraub, Roseanne D Dobkin, Michele K York, et al.
The Lancet. Neurology|December 23, 2021
The neuropsychiatry of Parkinson's disease: advances and challengesDaniel Weintraub, Dag Aarsland, Kallol Ray Chaudhuri, et al.
Pageof 7

Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
Journal of Geriatric Psychiatry and Neurology|June 28, 2018
Personalized Telemedicine for Depression in Parkinson's Disease: A Pilot TrialRoseanne D Dobkin, Alejandro Interian, John Logan Durland, et al.
The Journal of Trauma|October 1, 1995
Hypopituitarism secondary to transfacial gunshot woundM D'Angelica, C A Barba, A S Morgan, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 26, 2024
Defining the Importance of Minor Hallucinations in Parkinson's DiseaseRuth B Schneider, Kelly A Mills, Melissa J Nirenberg, et al.
Clinical Immunology and Immunopathology|January 1, 1976
Lymphokine properties of a lymphoid cultured cell supernatant fraction active in promoting tumor regressionB W Papermaster, O A Holtermann, E Klein, et al.
Journal of Pediatric Surgery|June 1, 1986
Comparative effects of dopamine, naloxone, and prostacyclin in the resuscitation of fecal-Escherichia coli peritonitis-induced septic shock in neonatal swineT E Lobe, E D Dobkin, D Gore, et al.
Clinical Case Studies|April 27, 2010
A Novel Approach to Treating Anxiety and Enhancing Executive Skills in an Older Adult with Parkinson's DiseaseJan Mohlman, Dorian Hunter Reel, Daniel Chazin, et al.
Journal of Geriatric Psychiatry and Neurology|April 17, 2013
Barriers to mental health care utilization in Parkinson's diseaseRoseanne D Dobkin, Jade Tiu Rubino, Jill Friedman, et al.
Neurology|April 3, 2020
Telephone-based cognitive behavioral therapy for depression in Parkinson disease: A randomized controlled trialRoseanne D Dobkin, Sarah L Mann, Michael A Gara, et al.
Annals of Neurology|May 13, 2026
Cognitive Impairment in Parkinson's Disease: Contributions from the Parkinson's Progression Markers InitiativeDaniel Weintraub, Roseanne D Dobkin, Michele K York, et al.
The Lancet. Neurology|December 23, 2021
The neuropsychiatry of Parkinson's disease: advances and challengesDaniel Weintraub, Dag Aarsland, Kallol Ray Chaudhuri, et al.
Pageof 7